Sermorelin Acetate 2mg

Quickstart Highlights

Sermorelin is a synthetic growth hormone–releasing hormone (GHRH) analog that stimulates endogenous pituitary GH secretion[1]. Originally approved for pediatric growth hormone deficiency, it is studied for adult off‑label use to support physiologic GH output and IGF‑1 levels[2]. This educational protocol presents a once‑daily subcutaneous approach administered at bedtime to align with natural nocturnal GH release[3].

Reconstitute: Add 3.0 mL bacteriostatic water → ~1.67 mg/mL concentration.
Typical daily range: 200–500 µg once daily at bedtime (gradual titration).
Easy measuring: At 1.67 mg/mL, 1 unit = 0.01 mL ≈ 16.7 µg on a U‑100 insulin syringe.
Storage: Lyophilized: refrigerate at 2–8 °C (36–46 °F); after reconstitution, refrigerate at 2–8 °C (36–46 °F) and use within 10–14 days[4]. Open source

Dosing & Reconstitution Guide

Educational guide for reconstitution and weekly dosing

Standard / Gradual Approach (3 mL = ~1.67 mg/mL)

Week	Daily Dose (µg)	Units (per injection) (mL)
Weeks 1–2	200 µg	12 units (0.12 mL)
Weeks 3–4	300 µg	18 units (0.18 mL)
Weeks 5–6	400 µg	24 units (0.24 mL)
Weeks 7–8	500 µg	30 units (0.30 mL)

Frequency: Inject once daily subcutaneously at bedtime. Bedtime administration is strongly recommended because endogenous GH secretion peaks during sleep[3]. This schedule uses the largest practical dilution (3.0 mL) to keep per‑injection units ≥10 for better accuracy. For ≤10‑unit (≤0.10 mL) administrations, consider 30‑ or 50‑unit insulin syringes for improved readability.

Reconstitution Steps

Reference-derived details for Sermorelin Acetate 2mg.

Draw 3.0 mL bacteriostatic water with a sterile syringe.
Inject slowly down the vial wall; gently swirl to dissolve (do not shake vigorously)[2]. Open source
Label with reconstitution date and refrigerate at 2–8 °C (36–46 °F), protected from light[2][4]. Open source
Wipe vial stopper with alcohol before each use; use a new sterile needle and syringe for each injection[2]. Open source

Supplies Needed

Plan based on an 8–week daily protocol with gradual titration (56 injections total).

Peptide Vials (Sermorelin, 5 mg each):
Peptide Vials (Sermorelin, 5 mg each):: 8 weeks (total ~19.6 mg consumed): 4 vials (20 mg total)
Peptide Vials (Sermorelin, 5 mg each):: 12 weeks (similar daily range): 6–7 vials
Peptide Vials (Sermorelin, 5 mg each):: Tip: Have 1 extra vial as backup in case of spillage or loss.
Insulin Syringes (U‑100):
Insulin Syringes (U‑100):: Per week: 7 syringes (1/day)
Insulin Syringes (U‑100):: 8 weeks: 56 syringes (recommend 1 × 100‑count box)
Insulin Syringes (U‑100):: 12 weeks: 84 syringes (1 × 100‑count box)
Insulin Syringes (U‑100):: Preferred: 0.3–0.5 mL size with 28G–31G needle, 5/16″ to 1/2″ length for subcutaneous use.
Bacteriostatic Water (10 mL bottles): Use ~3.0 mL per vial for reconstitution.
Bacteriostatic Water (10 mL bottles): Use ~3.0 mL per vial for reconstitution.: 8 weeks (4 vials): 12 mL → 2 × 10 mL bottles
Bacteriostatic Water (10 mL bottles): Use ~3.0 mL per vial for reconstitution.: 12 weeks (7 vials): 21 mL → 3 × 10 mL bottles
Bacteriostatic Water (10 mL bottles): Use ~3.0 mL per vial for reconstitution.: Contains benzyl alcohol preservative; do not use if allergic.
Alcohol Swabs: One for the vial stopper + one for the injection site each day.
Alcohol Swabs: One for the vial stopper + one for the injection site each day.: Per week: 14 swabs (2/day)
Alcohol Swabs: One for the vial stopper + one for the injection site each day.: 8 weeks: 112 swabs → recommend 2 × 100‑count boxes
Alcohol Swabs: One for the vial stopper + one for the injection site each day.: 12 weeks: 168 swabs → recommend 2 × 100‑count boxes
Sharps Container: One puncture‑proof disposal container for used needles (sufficient for 56+ syringes).

Protocol Overview

Concise summary of the once‑daily nightly regimen.

Goal: Stimulate endogenous pituitary GH release to support physiologic IGF‑1 levels and anabolic processes[1][2]. Open source
Schedule: Daily subcutaneous injections at bedtime for 3–6 months (pediatric trials ran 6–12 months; adult use is off‑label)[1]. Open source
Dose Range: 200–500 µg daily (adult research range; pediatric: 30 µg/kg nightly)[1][2]. Open source
Reconstitution: 3.0 mL per 5 mg vial (~1.67 mg/mL) for accurate unit measurements.
Storage: Lyophilized refrigerated; reconstituted refrigerated and used within 10–14 days[4]. Open source

Dosing Protocol

Suggested nightly titration approach for adult off‑label use.

Start: 200 µg nightly at bedtime; increase by ~100 µg every 1–2 weeks as tolerated.
Target: 300–500 µg nightly by Weeks 5–8 (adjust based on IGF‑1 response).
Frequency: Once per day (subcutaneous, preferably before sleep)[3]. Open source
Cycle Length: 3–6 months typical for adult research use; pediatric trials ran 6–12 months[1]. Open source
Timing: Bedtime administration leverages natural nocturnal GH pulse; rotate injection sites systematically[7]. Open source

Storage Instructions

Proper storage preserves peptide potency and sterility.

Lyophilized: Store at 2–8 °C (36–46 °F) in dry, dark conditions[2]. Do not freeze dry powder; check expiration date. Open source
Reconstituted: Refrigerate at 2–8 °C (36–46 °F)[4]; do not freeze mixed solution[4]. Use within 10–14 days when using bacteriostatic water (multi‑dose vial). Open source
Allow vials to reach room temperature before reconstituting to aid dissolution; inspect solution before each use (should be clear and colorless)[2]. Open source
Always use aseptic technique: swab stopper with alcohol before each draw; use new sterile needle and syringe per injection[2]. Open source

Important Notes

Practical considerations for consistency, safety, and optimal response.

Bedtime dosing is critical: Sermorelin works best when administered before sleep to align with the natural nocturnal GH pulse[3]. Open source
Use new sterile insulin syringes; dispose in a designated sharps container after each use[7]. Open source
Rotate injection sites systematically (abdomen, thighs, upper arms) to prevent irritation or lipohypertrophy[7]. Open source
Inject slowly subcutaneously; wait a few seconds before withdrawing the needle to ensure full delivery.
Monitor IGF‑1 levels at baseline and periodically (every 1–2 months) to confirm response and adjust dosing if needed.
Check thyroid function if using long‑term, as subclinical hypothyroidism can blunt GH response[5]. Open source
Document daily dose, time, and injection site in a log for adherence and troubleshooting.

How This Works

Sermorelin is a synthetic analog of growth hormone–releasing hormone (GHRH) that binds to GHRH receptors on pituitary somatotropes, stimulating endogenous pulsatile GH secretion[1]. Unlike exogenous GH administration, sermorelin preserves physiologic feedback loops—GH release is subject to normal negative feedback via somatostatin and IGF‑1, reducing the risk of excessive GH or IGF‑1 levels[6]. This pulsatile GH output then promotes hepatic and peripheral IGF‑1 production, supporting anabolic processes such as protein synthesis, lipolysis, and tissue repair. Pediatric studies in idiopathic GH deficiency demonstrated significant improvements in height velocity over 6–12 months of nightly subcutaneous therapy at 30 µg/kg[1]. In adults, off‑label use aims to restore age‑related declines in GH output, though robust adult trial data are limited and dosing is extrapolated from pediatric and physiologic studies[2]. Sermorelin requires a functional pituitary to be effective and will not work in cases of pituitary damage or primary GH gene defects.

Lifestyle Factors

Complementary strategies to optimize GH response and overall outcomes.

Sleep quality: Prioritize 7–9 hours of uninterrupted sleep nightly to maximize natural GH pulse and sermorelin efficacy.
Nutrition: Consume adequate protein (1.6–2.2 g/kg/day) to support anabolic processes; avoid high‑carbohydrate meals immediately before bedtime (can blunt GH release).
Exercise: Combine resistance training (3–5×/week) and moderate aerobic activity to amplify GH/IGF‑1 benefits on muscle mass, fat loss, and metabolic health.
Stress management: Chronic stress elevates cortisol, which can suppress GH secretion; practice stress‑reduction techniques (meditation, yoga, adequate rest).
Avoid alcohol and smoking: Both can impair GH release and blunt sermorelin response.

Potential Benefits & Side Effects

Observations from pediatric clinical trials and adult off‑label research.

Stimulates endogenous pulsatile GH release, supporting physiologic IGF‑1 elevation[1][2]. Open source
In pediatric GH deficiency: significant improvements in height velocity and growth parameters over 6–12 months[1]. Open source
In adults (off‑label): may support favorable changes in body composition, energy, recovery, and metabolic markers (evidence limited; effects more modest than direct GH therapy)[6]. Open source
Preserves physiologic feedback, reducing risk of supraphysiologic GH or IGF‑1 levels compared to exogenous GH[6]. Open source
Injection‑site reactions (most common): Transient redness, pain, or swelling at injection site (~17% incidence in trials)[5]. Open source
Rare systemic effects (<1%): Headache, flushing, dizziness, hyperactivity, drowsiness, or hives[5]. Open source
Thyroid considerations: ~6.5% of patients developed subclinical hypothyroidism in one study[5]; untreated hypothyroidism can blunt GH response[5]. Open source
No serious acromegaly, hypoglycemia, or excessive IGF‑1 elevations reported at recommended dosages (built‑in negative feedback prevents overshooting).

Injection Technique

General subcutaneous guidance from clinical best‑practice resources[7][8].

Gather materials: Reconstituted sermorelin vial, new insulin syringe (with needle attached), alcohol swab, cotton ball or bandage.
Choose injection site: Abdomen (at least 2 inches from navel), outer thigh, upper outer arm, or buttocks—areas with subcutaneous fat layer[7]. Open source
Rotate sites: Use a systematic rotation to prevent irritation or lipoatrophy; do not inject into the exact same spot each time (keep at least 1–2 inches apart)[7]. Open source
Clean vial stopper and skin: Swab vial stopper with alcohol; clean injection site with alcohol swab in 2‑inch diameter; allow to dry completely[7]. Open source
Draw dose: Remove needle cap; draw air equal to dose volume; inject air into vial; invert and draw prescribed dose; expel air bubbles.
Pinch and insert: Pinch a fold of skin; insert needle at 45–90° angle (depending on needle length and fat thickness) into subcutaneous tissue[7][8]. Do not aspirate for subcutaneous injections[8]. Open source
Inject: Slowly depress plunger over a couple of seconds; wait 1–2 seconds before withdrawing needle at same angle.
Post‑injection: Apply gentle pressure with cotton ball or alcohol pad; do not rub the site[7]. If slight bleeding, apply bandage. Open source
Dispose: Immediately dispose of needle and syringe in designated sharps container; never recap needle[7]. Open source
Pain or lumps: Ensure injecting into fatty tissue (not too shallow into skin or too deep into muscle); rotate sites consistently.
Injection‑site reactions: Mild redness/swelling is common (~17%); give that area a longer break before reusing[5]. Open source
Cold solution discomfort: Let refrigerated vial warm to room temperature for ~30 minutes before injection (optional).

Recommended Source

We recommend Prime Lab Peptides for high‑purity Sermorelin (5 mg).

High‑purity, third‑party‑tested lots with batch Certificates of Analysis (COAs) available on request.
Consistent, ISO‑aligned handling, documentation, and quality control.
Reliable fulfillment to maintain cold‑chain integrity during shipment.
Transparent sourcing and manufacturing standards for research‑grade peptides.
Shop at Prime Lab Peptides

Important Note

This page is informational and does not authorize use. Peptify clients should complete assessment, disclose medications and health history, and follow the clinician-approved plan only.

Do not start, stop, combine, or change a protocol based only on website content.
Emergency symptoms require urgent medical care, not a website or routine follow-up message.

References